🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Congratulations Prof Phoebe Phillips, AM recognised with a Member of the Order of Australia (AM) in 2022 for services to #pancreaticcancer #research. @PanKind_APCF is proud to have funded Prof Phillip's research work in 2016, 2018 & 2021 making a significant difference to patients 💜👏

The always inspirational Prof Phoebe Phillips ⁦Prof Phoebe Phillips, AM⁩ speaking at the ⁦UNSW Medicine & Health⁩ Cancer Theme Symposium #pancreaticcancer #translationalresearch

The full program is now available for the NSW Cancer Conference. Get in quick, there are limited tickets left. nswcancerconference.com.au #NSWCancerConf22 #workingtogether #cancerresearch

Check out Cancer Research's newest collection, Targeting the Tumor Microenvironment: bit.ly/3djy2yq

Well done Prof Phoebe Phillips, AM Joshua McCarroll George Sharbeen and collaborators on this great research paper UNSW Medicine & Health Childrens Cancer Institute

Remember to register for NSW Cancer Conference !! Can’t wait to see you all there 😍

Promising preclinical results have been reported for Noxopharm Limited's new pancreatic cancer drug. The drug was tested using UNSW #Medicine's novel patient-derived tumour explant model, developed by Prof Phoebe Philips AM Prof Phoebe Phillips, AM and Dr John Kokkinos John Kokkinos:

The big day has arrived. Welcome to all our delegates. So great to see everyone this morning. #NSWCancerConf22.

Day 2 of the #NSWCancerConf22 - a networking breakfast sponsored by UNSW Medicine & Health featuring Elgene Lim, Marina Pajic and David Goldstein

“Everybody in this room is helping to answer the wishes of people impacted by cancer.” - NSW Premier Dominic Perrottet addresses the dedication and impact of cancer researchers across the state. #cancerNSWawards

Congratulations A/Prof Natalie Taylor! So well deserved #cancerNSWawards SPHERE Cancer Clinical Academic Group

Prof Phoebe Phillips, Lead Pancreatic Cancer Translational Research Group, Deputy-Director at SPHERE & Assoc. Dean ⁦UNSW Medicine & Health⁩ opens Translational Research Symposium ⁦GI Cancer Institute and AGITG⁩ #AGITG22 #ASM2022

Prof ⁦Prof Phoebe Phillips, AM⁩ opened the Translational Science Symposium at #AGITG22 with Jeff Cuff highlighting the importance of incorporating a #translational component in #GIcancer research

Very happy to see our recent work published in Cell Reports Medicine ! We show that triggering senescence with conventional chemotherapy improves the response to immune-checkpoint blockade in breast cancer brain metastasis. cell.com/cell-reports-m… Rebeca Uceda Van Rheenen Lab

Today is #worldpancreaticcancerday a day @PanKind_APCF stands united with other global organisations to highlight the need for increased awareness, greater focus & more funding for #pancreaticcancer research. #ItsAboutTime to learn more & do more about the disease.#WPCD W P C C

We are proud to announce on #WPCD cancer day, the successful 2022 Research Grant recipients to share in $1.6 million of funding to progress #pancreaticcancer research in the areas of #EarlyDetection and #NewTreatments. Read more: bit.ly/3UOiXWD #CancerResearch

Congratulations to the new #NHMRC Postgraduate Scholars starting in 2023. Dr Omali Pitiyarachchi from UNSW will use her Postgraduate Scholarship to progress personalised treatment for patients with pancreatic cancer. Find out more 👉 nhmrc.gov.au/about-us/news-…

Published in Med by Cell Press Single-cell mapping reveals several immune subsets associated with liver metastasis of #PancreaticCancer cell.com/med/fulltext/S… In this study of 11 patients, high dimensional imaging mass cytomtery was used to identify an immune signature in the

The vast majority of people diagnosed with pancreatic cancer won't live beyond five years. But, a potential drug breakthrough could buy patients more time. Dr. Nick Coatsworth #9News

New research into targeted therapies for #pancreaticcancer treatment was discussed in Session 2. Some fascinating talks from Prof Claudine Bonder, Prof Frederic Hollande, Prof Nigel Turner, Dr Katia Nones, Dr George Sharbeen & A/Prof Thomas R. Cox. #PanKindScience23